CLIA Waiver for QuickVue® RSV Test
go back to news archives Quidel Corporation has announced that the U.S. Food and Drug Administration (FDA) granted CLIA waiver for the QuickVue® RSV test for the qualitative detection of respiratory syncytial virus (RSV). The waiver makes the QuickVue RSV test more widely available for use, especially in physician offices and clinics where waived tests are used most frequently. The QuickVue RSV test is simple and accurate, with high sensitivity and specificity. Respiratory syncytial virus is recognized by the American Academy of Pediatrics as the leading cause of pneumonia and bronchiolitis among children two years of age and younger. RSV is a common virus with symptoms that often resemble the common cold. The QuickVue RSV test is intended for use as an aid in the diagnosis of acute RSV viral infections for symptomatic pediatric patients. |
NOTE: This item is from our 'historic' database and
may contain information which is not up to date.
Source : Quidel Corporation View Company Information
Posted on March 7, 2008
LATEST MICROBIOLOGY NEWS
-
New Self-collection Devices from MWE
01 Jul 2025
MICROBIOLOGY EVENTS
-
Main Challenges in Allergen Testing and How to Overcome Them
9 Jul 2025 -
Getting Equipped for the Future with the New MAS-100 Sirius® Microbial Air Sampler
10 Jul 2025 -
Unmasking Endotoxins: A Sample Preparation Strategy to Overcome LER
15 Jul 2025 -
IAFP 2025
27 Jul 2025 -
ADLM 2025
27 Jul 2025 -
Food Safety Culture Workshop
9 Sep 2025 -
Who are the "Real" Spoilers in Food?
11 Sep 2025 -
CPD accredited course: Level 3 HACCP & Food Safety
15 Sep 2025 -
Culture Eats HACCP for Breakfast (free)
On-demand Webinar -
A3P International Congress 2025
7 Oct 2025